Financial overview

Xspray Pharma financial report data and keyfigures. History for income statement, balance sheet and cash flow.

Pre
Pre
Pre

Description

Xspray Pharma is a pharmaceutical company with the goal of improving the quality of life for cancer patients. The company has several product candidates in the clinical development phase and plans to launch its first product on the US market during september 2024. Based on a patented technology for the amorphous formulation of drugs, the company develops product candidates with relevant medical benefits that should be able to be marketed as improved versions of established drugs for the treatment of cancer (protein kinase inhibitors, PKIs).

Biotechnology